Asensus Surgical

ASXCAMEX
$0.324000
15 minutes delayed
Consensus Rating1
Neutral
Highest Price Target1
$0.35
Lowest Price Target1
$0.35
Consensus Price Target1
$0.17

Asensus Surgical (AMEX:ASXC) Stock, Analyst Ratings, Price Targets, Predictions

Asensus Surgical Inc has a consensus price target of $0.17, established from looking at the 13 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co. on May 16, 2024, April 4, 2024, and March 22, 2024. With an average price target of $0.9 between HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co., there's an implied 178.47% upside for Asensus Surgical Inc from these 3 analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Mar
1
Apr
1
May
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.0
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Cantor Fitzgerald

1calculated from analyst ratings

Analyst Ratings for Asensus Surgical

Buy NowGet Alert
05/16/2024Buy Now8.29%HC Wainwright & Co.
Swayampakula Ramakanth
→ $0.35ReiteratesNeutral → NeutralGet Alert
04/04/2024Buy Now8.29%HC Wainwright & Co.
Swayampakula Ramakanth
$2 → $0.35DowngradeBuy → NeutralGet Alert
03/22/2024Buy Now518.81%HC Wainwright & Co.
Swayampakula Ramakanth
$2 → $2MaintainsBuyGet Alert
11/16/2023Buy NowCantor Fitzgerald
Ross Osborn
DowngradeOverweight → NeutralGet Alert
11/15/2023Buy Now518.81%HC Wainwright & Co.
Swayampakula Ramakanth
→ $2ReiteratesBuy → BuyGet Alert
08/22/2023Buy Now209.41%Cantor Fitzgerald
Ross Osborn
→ $1ReiteratesOverweight → OverweightGet Alert
08/11/2023Buy Now518.81%HC Wainwright & Co.
Swayampakula Ramakanth
→ $2ReiteratesBuy → BuyGet Alert
05/12/2023Buy Now518.81%HC Wainwright & Co.
Swayampakula Ramakanth
→ $2ReiteratesBuy → BuyGet Alert
03/06/2023Buy Now518.81%HC Wainwright & Co.
Swayampakula Ramakanth
$3 → $2MaintainsBuyGet Alert
02/22/2023Buy Now828.22%HC Wainwright & Co.
Swayampakula Ramakanth
→ $3Reiterates → BuyGet Alert
01/10/2023Buy Now828.22%HC Wainwright & Co.
Swayampakula Ramakanth
→ $3Reiterates → BuyGet Alert
09/08/2022Buy Now364.11%Cantor Fitzgerald
Ross Osborn
→ $1.5Initiates → OverweightGet Alert
08/10/2022Buy Now828.22%HC Wainwright & Co.
Swayampakula Ramakanth
$4 → $3MaintainsBuyGet Alert

FAQ

Q

What is the target price for Asensus Surgical (ASXC) stock?

A

The latest price target for Asensus Surgical (AMEX:ASXC) was reported by HC Wainwright & Co. on May 16, 2024. The analyst firm set a price target for $0.35 expecting ASXC to rise to within 12 months (a possible 8.02% upside). 7 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Asensus Surgical (ASXC)?

A

The latest analyst rating for Asensus Surgical (AMEX:ASXC) was provided by HC Wainwright & Co., and Asensus Surgical reiterated their neutral rating.

Q

When was the last upgrade for Asensus Surgical (ASXC)?

A

There is no last upgrade for Asensus Surgical

Q

When was the last downgrade for Asensus Surgical (ASXC)?

A

The last downgrade for Asensus Surgical Inc happened on April 4, 2024 when HC Wainwright & Co. changed their price target from $2 to $0.35 for Asensus Surgical Inc.

Q

When is the next analyst rating going to be posted or updated for Asensus Surgical (ASXC)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Asensus Surgical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Asensus Surgical was filed on May 16, 2024 so you should expect the next rating to be made available sometime around May 16, 2025.

Q

Is the Analyst Rating Asensus Surgical (ASXC) correct?

A

While ratings are subjective and will change, the latest Asensus Surgical (ASXC) rating was a reiterated with a price target of $0.35 to $0.35. The current price Asensus Surgical (ASXC) is trading at is $0.32, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch